152 related articles for article (PubMed ID: 17108213)
1. Real-time quantification of human telomerase reverse transcriptase mRNA in the plasma of patients with prostate cancer.
Dasí F; Martínez-Rodes P; March JA; Santamaría J; Martínez-Javaloyas JM; Gil M; Aliño SF
Ann N Y Acad Sci; 2006 Sep; 1075():204-10. PubMed ID: 17108213
[TBL] [Abstract][Full Text] [Related]
2. Real time quantification in plasma of human telomerase reverse transcriptase (hTERT) mRNA in patients with colorectal cancer.
Lledó SM; Garcia-Granero E; Dasí F; Ripoli R; García SA; Cervantes A; Aliño SF
Colorectal Dis; 2004 Jul; 6(4):236-42. PubMed ID: 15206965
[TBL] [Abstract][Full Text] [Related]
3. Plasma hTERT mRNA discriminates between clinically localized and locally advanced disease and is a predictor of recurrence in prostate cancer patients.
March-Villalba JA; Martínez-Jabaloyas JM; Herrero MJ; Santamaría J; Aliño SF; Dasí F
Expert Opin Biol Ther; 2012 Jun; 12 Suppl 1():S69-77. PubMed ID: 22559196
[TBL] [Abstract][Full Text] [Related]
4. Human telomerase reverse transcriptase expression and its clinical significance in laryngeal squamous cell carcinoma.
Li YR; Wu JM; Wang L; Huang X; Shi J; Hu LH
Acta Otolaryngol; 2005 Apr; 125(4):409-14. PubMed ID: 15823813
[TBL] [Abstract][Full Text] [Related]
5. Expression of human telomerase reverse transcriptase, Survivin, DD3 and PCGEM1 messenger RNA in archival prostate carcinoma tissue.
Bialkowska-Hobrzanska H; Driman DK; Fletcher R; Harry V; Razvi H
Can J Urol; 2006 Feb; 13(1):2967-74. PubMed ID: 16515751
[TBL] [Abstract][Full Text] [Related]
6. DD3(PCA3), a very sensitive and specific marker to detect prostate tumors.
de Kok JB; Verhaegh GW; Roelofs RW; Hessels D; Kiemeney LA; Aalders TW; Swinkels DW; Schalken JA
Cancer Res; 2002 May; 62(9):2695-8. PubMed ID: 11980670
[TBL] [Abstract][Full Text] [Related]
7. Real-time quantification of human telomerase reverse transcriptase mRNA in liver tissues from patients with hepatocellular cancer and chronic viral hepatitis.
Satra M; Gatselis N; Iliopoulos D; Zacharoulis D; Dalekos GN; Tsezou A
J Viral Hepat; 2007 Jan; 14(1):41-7. PubMed ID: 17212643
[TBL] [Abstract][Full Text] [Related]
8. A prospective evaluation of the diagnostic and potential prognostic utility of urinary human telomerase reverse transcriptase mRNA in patients with bladder cancer.
Bowles L; Bialkowska-Hobrzanska H; Bukala B; Nott L; Razvi H
Can J Urol; 2004 Dec; 11(6):2438-44. PubMed ID: 15636669
[TBL] [Abstract][Full Text] [Related]
9. Quantitative real-time reverse transcription: polymerase chain reaction of prostate-specific antigen (PSA) for detection of circulating prostatic cells in patients with clinically localized prostate cancer.
Llanes L; Ferruelo A; Luján M; Pascual C; García-Mediero JM; Berenguer A
Prostate Cancer Prostatic Dis; 2005; 8(3):248-52. PubMed ID: 15897916
[TBL] [Abstract][Full Text] [Related]
10. Differential display code 3 (DD3/PCA3) in prostate cancer diagnosis.
Klecka J; Holubec L; Pesta M; Topolcan O; Hora M; Eret V; Finek J; Chottova-Dvorakova M; Babjuk M; Novak K; Stolz J
Anticancer Res; 2010 Feb; 30(2):665-70. PubMed ID: 20332487
[TBL] [Abstract][Full Text] [Related]
11. Serum human telomerase reverse transcriptase messenger RNA as a novel tumor marker for hepatocellular carcinoma.
Miura N; Maeda Y; Kanbe T; Yazama H; Takeda Y; Sato R; Tsukamoto T; Sato E; Marumoto A; Harada T; Sano A; Kishimoto Y; Hirooka Y; Murawaki Y; Hasegawa J; Shiota G
Clin Cancer Res; 2005 May; 11(9):3205-9. PubMed ID: 15867214
[TBL] [Abstract][Full Text] [Related]
12. Quantitative assessment of telomerase activity and human telomerase reverse transcriptase messenger RNA levels in pancreatic juice samples for the diagnosis of pancreatic cancer.
Ohuchida K; Mizumoto K; Ogura Y; Ishikawa N; Nagai E; Yamaguchi K; Tanaka M
Clin Cancer Res; 2005 Mar; 11(6):2285-92. PubMed ID: 15788678
[TBL] [Abstract][Full Text] [Related]
13. Multiple tumor marker analyses (PSA, hK2, PSCA, trp-p8) in primary prostate cancers using quantitative RT-PCR.
Fuessel S; Sickert D; Meye A; Klenk U; Schmidt U; Schmitz M; Rost AK; Weigle B; Kiessling A; Wirth MP
Int J Oncol; 2003 Jul; 23(1):221-8. PubMed ID: 12792797
[TBL] [Abstract][Full Text] [Related]
14. [Quantitative detection of differential display code 3 mRNA in peripheral blood of patients with prostate cancer].
Weng ZL; Yu KY; Mao XL; Tao ZH; Chen XD; Wu XL; Hu YP; Wang SQ; Li CD; Chen ZG
Zhonghua Yi Xue Za Zhi; 2006 Nov; 86(41):2911-5. PubMed ID: 17288789
[TBL] [Abstract][Full Text] [Related]
15. The use of real-time reverse transcription-PCR for prostate-specific antigen mRNA to discriminate between blood samples from healthy volunteers and from patients with metastatic prostate cancer.
Patel K; Whelan PJ; Prescott S; Brownhill SC; Johnston CF; Selby PJ; Burchill SA
Clin Cancer Res; 2004 Nov; 10(22):7511-9. PubMed ID: 15569981
[TBL] [Abstract][Full Text] [Related]
16. Real-time quantitative analysis for human telomerase reverse transcriptase mRNA and human telomerase RNA component mRNA expressions as markers for clinicopathologic parameters in urinary bladder cancer.
Takihana Y; Tsuchida T; Fukasawa M; Araki I; Tanabe N; Takeda M
Int J Urol; 2006 Apr; 13(4):401-8. PubMed ID: 16734859
[TBL] [Abstract][Full Text] [Related]
17. Relationship between tumor and plasma levels of hTERT mRNA in patients with colorectal cancer: implications for monitoring of neoplastic disease.
Terrin L; Rampazzo E; Pucciarelli S; Agostini M; Bertorelle R; Esposito G; DelBianco P; Nitti D; De Rossi A
Clin Cancer Res; 2008 Nov; 14(22):7444-51. PubMed ID: 19010861
[TBL] [Abstract][Full Text] [Related]
18. A diagnostic evaluation of serum human telomerase reverse transcriptase mRNA as a novel tumor marker for gynecologic malignancies.
Miura N; Kanamori Y; Takahashi M; Sato R; Tsukamoto T; Takahashi S; Harada T; Sano A; Shomori K; Harada T; Kigawa J; Ito H; Terakawa N; Hasegawa J; Shiota G
Oncol Rep; 2007 Mar; 17(3):541-8. PubMed ID: 17273731
[TBL] [Abstract][Full Text] [Related]
19. [Detection of telomerase activity by semi-quantitative and in situ assays and quantification of hTERT expression in bladder carcinomas].
Longchampt E; Lebret T; Molinie V; Bieche I; Botto H; Lidereau R
Prog Urol; 2003 Apr; 13(2):238-45. PubMed ID: 12765058
[TBL] [Abstract][Full Text] [Related]
20. Quantification of human telomerase RNA (hTR) and human telomerase reverse transcriptase (hTERT) mRNA in testicular tissue of infertile patients.
Schrader M; Müller M; Heicappell R; Straub B; Miller K
Asian J Androl; 2001 Dec; 3(4):263-70. PubMed ID: 11753470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]